Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Matthew J Kacsmaryk

Hotel Sex Trafficking Suit Can Proceed, Inviting Hotels to Profile and Harass Guests

Can a hotel be guilty of sex trafficking just because it didn't surveil its customers enough?

Reason

Federal judge strikes down workplace protections for transgender workers

A federal judge in Texas struck down guidance from a government agency specifying protections against workplace harassment based on gender identity and sexual orientation

The Independent UK

Judge rejects case against Jack Smith

Texas Attorney General Ken Paxton had sought to prevent Jack Smith from destroying records related to Trump cases

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

John Oliver on Trump: ‘He’s reshaped the judiciary from top to bottom’

The Last Week Tonight host looks into how Trump’s presidency shifted the US judiciary far rightward – and what could happen if he’s elected again

The Guardian - US

SCOTUS rejects abortion drug challenge

The court ruled unanimously against Alliance for Hippocratic Medicine, preserving access to mifepristone

Salon

Slippery slope of abortion drug lawsuit

Vaccines, gender-affirming care and birth control could be next if SCOTUS rules to restrict nationwide access

Salon

In front of Supreme Court, a nation divided on abortion drug - Roll Call

In front of the Supreme Court, both sides of the abortion debate squared off over the use of the drug mifepristone.

Roll Call

Read news from The Economist, FT, and more,
with one subscription

Will Abortion Issues Return to the Supreme Court?

The Court has been asked to intervene in cases involving abortion pills and criminal prosecution of abortion doctors.

Reason

Federal court rules in favor of Biden ESG retirement rule

Economy and Society is Ballotpedia’s weekly review of the developments in corporate activism; corporate political engagement; and the environmental, social, and corporate governance (ESG) trends and events that characterize the growing intersection between business and politics.

Ballotpedia

Challenging the FDA's authority isn't new – the agency's history shows what's at stake when drug regulation is in limbo

Political pressure is nothing new for the U.S. Food and Drug Administration. The agency has frequently come under fire for its drug approval decisions, but attacks on its decision-making process and science itself have increased during the COVID-19 pandemic.

The Conversation

California leaders celebrate abortion pill access after Supreme Court decision

SACRAMENTO, Calif. — California leaders commended Friday’s U.S. Supreme Court decision that will temporarily preserve access to abortion pills, doubling down on their push to protect reproductive services in the Golden State.

Tribune News Service

SCOTUS: Abortion pill is safe — for now

SCOTUS reversed a federal judge's previous ruling that banned mifepristone, a pill intrinsic to medication abortion

Salon

Supreme Court sides with FDA on abortion pills, blocks Texas rulings for now

WASHINGTON — The Supreme Court on Friday ruled for the Biden administration to preserve legal access in most of the nation to an abortion pill that is part of the most common method of ending early pregnancies.

Los Angeles Times

A Mifepristone Suspension Would Have Significant Ripple Effects Beyond Abortion

Mifepristone is currently used to treat a handful of conditions, including Cushing’s syndrome. A suspension would affect more than those seeking medication abortions.

Inverse

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

Abortion pill case deadline extended

The Supreme Court is ruling on a district court's attempt to ban the abortion pill mifepristone

Salon

Medication abortions still in limbo

Legal experts weigh in on what to expect with the mifepristone case this week

Salon

Abortion judge may have hid law article

"Why did Judge Kacsmaryk mislead the American people during his confirmation hearing?" congressman questions

The Conversation

Anti-mifepristone court decisions rely on medical misinformation about abortion and questionable legal reasoning

An early April 2023 decision by a U.S. district judge in Texas to reverse 23 years of approval of the abortion pill mifepristone has sparked explosive debate.

Get all your
news in one place.

100's of premium titles.
One news app.

Reason

The Unprecedented Judicial Move in the Texas Abortion Pill Decision

It’s not the FDA’s job to tell doctors what to do.

Fortune

How employers should respond to dueling rulings that reveal the uncertainty of abortion access in the U.S.

Companies can speak up, engage with lawmakers, and communicate to their workforces.

The Independent UK

What does 1870s Comstock Act have to do with abortion pills?

A 19th century “anti-vice” law is at the center of a new court ruling that threatens access to the leading abortion drug in the U.S. Dormant for a half-century, the Comstock Act is being been revived by groups seeking to block the mailing of mifepristone, the pill used in more…

Chicago Sun-Times

Access to abortion pill in limbo after competing rulings

Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years.

The Independent UK

Judge halts FDA approval of abortion pill mifepristone

A federal judge in Texas has thrown into jeopardy the most common method of abortion in the U.S., ordering regulators to temporarily halt their approval of the drug mifepristone for abortion

People

[ Brett M. ] Kavanaugh

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.